Reuters logo
BRIEF-Intellipharma says Par Pharma launches additional strengths of generic Focalin
May 24, 2017 / 8:22 PM / in 6 months

BRIEF-Intellipharma says Par Pharma launches additional strengths of generic Focalin

May 24 (Reuters) - Intellipharmaceutics International Inc

* Intellipharmaceutics reports on launch of additional strengths of generic focalin xr® by par pharmaceutical

* Intellipharmaceutics - par pharmaceutical has launched 10 and 20 mg strengths of its generic focalin xr capsules in u.s

* Intellipharmaceutics international inc says expects remaining 5 and 40 mg strengths to be launched in near future

* Intellipharmaceutics -under a licensing and commercialization , co receives quarterly profit-share payments on par’s u.s. Sales of generic focalin xr Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below